These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 6887275)
1. Low-dose procainamide: low risk of complications with long-term use. van Pham C; Noguchi J; Quismorio FP; Haywood LJ J Natl Med Assoc; 1983 Jul; 75(7):705-8. PubMed ID: 6887275 [TBL] [Abstract][Full Text] [Related]
2. A systemic lupus erythematosus-like syndrome induced by procainamide. Zeide MS; Wiesel S; Terry R; Stein D Clin Orthop Relat Res; 1978; (134):290-2. PubMed ID: 729256 [TBL] [Abstract][Full Text] [Related]
3. Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation. Giardina EG; Fenster PE; Bigger JT; Mayersohn M; Perrier D; Marcus FI Am J Cardiol; 1980 Nov; 46(5):855-62. PubMed ID: 6159783 [TBL] [Abstract][Full Text] [Related]
4. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574 [TBL] [Abstract][Full Text] [Related]
5. [Lupus erythematosus-like syndrome induced by long-term treatment with procainamide]. Wierzchowiecki M; Rybicka K Pol Arch Med Wewn; 1978 Feb; 59(2):197-201. PubMed ID: 758078 [No Abstract] [Full Text] [Related]
6. Large dose procainamide therapy for ventricular tachyarrhythmia. Greenspan AM; Horowitz LN; Spielman SR; Josephson ME Am J Cardiol; 1980 Sep; 46(3):453-62. PubMed ID: 6968154 [No Abstract] [Full Text] [Related]